News

Do you often wake up with jaw pain or experience frequent headaches? You might be dealing with symptoms of a condition known ...
“ATR-258, a synthetic small molecule, has favourable pharmacokinetics and in Phase 1 clinical trials has been administered just once a day as a capsule, making it a straightforward, patient-friendly ...
Atrogi's breakthrough discovery enables chronic use of next-generation, highly selective β2-agonists for the first time in metabolic disease ...
Figure 1, published in Cell. Discovery of adrenergic receptor agonists that increase glucose uptake with low cAMP generationNovel drug candidate ...
How First-Time Users Can Build Muscle with Confidence’ Ultimate Beginner’s Guide to Steroid Cycles: Safe, Legal, and Effective Alternatives for Muscle Growth and Performance in 2025 Launches By ...
Supercede Therapeutics, Inc., a startup biotech company focused on small molecule drug development, today announced preclinical efficacy data from its lead therapeutic program to treat obesity.
Plus, a few names rising up the draft board and more quotes and insights gathered over the course of the season.
Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...
This is why she recommends that women over 50 cut out alcohol before bed. “While you may feel that it helps you fall asleep ...
Three years after its approval in the U.S., Radicava ORS has been prescribed to more than 13,500 ALS patients, Mitsubishi ...